Corporate News     10-Jun-22
Alembic Pharmaceuticals gets USFDA approval
For Dasatinib Tablets
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Sprycel Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, of Bristol Myers Squibb Company (BMS). Dasatinib Tablet is indicated for the treatment of adult patients with i) newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. ii) chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. iii) Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Previous News
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 30-Nov-23   14:30 )
  Alembic Pharma's Panelav unit successfully completes USFDA inspection
 ( Corporate News - 26-Jul-24   13:36 )
  Alembic Pharma gains after receiving US FDA nod for psoriasis treatment drug Acitretin
 ( Hot Pursuit - 07-Aug-24   13:12 )
  Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 26-Aug-24   09:55 )
  USFDA inspects Alembic Pharmaceuticals' Karkhadi unit
 ( Corporate News - 24-Mar-23   16:33 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution
 ( Hot Pursuit - 04-Oct-24   09:29 )
  Alembic Pharma Q2 PAT falls 19% YoY; R&D spend at Rs 168 crore
 ( Hot Pursuit - 11-Nov-22   14:21 )
  Alembic Pharma karkhadi facility gets two USFDA observations
 ( Hot Pursuit - 25-Mar-23   12:35 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Camlin Fine Sciences Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Nov-23   12:00 )
Other Stories
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
  Reliance Industrial InfraStructure declare Quarterly Result
  05-Oct-24   10:11
  PVV Infra to convene board meeting
  05-Oct-24   10:06
  Avenue Supermarts declare Quarterly Result
  05-Oct-24   10:06
  Fortis Healthcare to hold board meeting
  05-Oct-24   10:06
  Syngene International to convene board meeting
  05-Oct-24   10:06
  Srestha Finvest to conduct board meeting
  05-Oct-24   10:06
  Spright Agro schedules board meeting
  05-Oct-24   10:05
Back Top